Shimrit Ringelstein-Harlev

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 2

Top Topics

Chronic Lymphocytic Leukemia

Ejection Fraction

Prognostic Factors

Top Venues

Cancer immunology, immunotherapy : CII

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Shimrit Ringelstein-Harlev, Mona Fanadka, Netanel A Horowitz, Noam P Bettman, Tami Katz
In chronic lymphocytic leukemia, activation of the thrombopoietin receptor promotes T-cell inhibitory properties, contributing to immunosuppression. European journal of haematology (2022)
Tehila Azoulay, Ilana Slouzky, Michal Karmona, Margarita Filatov, Michal Hayun, Yishai Ofran, Galit Sarig, Shimrit Ringelstein-Harlev
Compromised activity of natural killer cells in diffuse large b-cell lymphoma is related to lymphoma-induced modification of their surface receptor expression. Cancer immunology, immunotherapy : CII (2022)